Clinical Trial

Phase II Study of Platinum (Cisplatin/Carboplatin)and Polymeric Micelles Paclitaxel(Pm-Pac) With Ivonescimab in First Line Metastatic Squamous NSCLC.

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is a prospective, single-arm, multi-center, phase Ⅱ trial to evaluate the efficacy and safety of Polymeric Micelles paclitaxel(pm-Pac), platinum (cisplatin/carboplatin) in combination with Ivonescimab as first-line treatment in metastatic squamous NSCLC patients.
Trial Details
NCT Number NCT07009925
Lead Sponsor Jiangsu Cancer Institute & Hospital
Conditions Squamous Cell Lung Cancer
Enrollment 38 participants
Start Date 2025-06
Primary Completion 2027-05 (estimated)
Study Completion 2028-05 (estimated)
Updated on ClinicalTrials.gov 2025-06-08